Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment

Duke University4 sites in 1 country338 target enrollmentNovember 2012

ConditionsChildhood Leukemia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Childhood Leukemia
Sponsor: Duke University
Enrollment: 338
Locations: 4
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.

Detailed Description

A repeated measures research design will evaluate phenotypic and genotypic treatment-related symptom associations experienced by children and adolescents 3-17 years of age with a diagnosis of leukemia.

Registry

clinicaltrials.gov

Start Date

November 2012

End Date

August 1, 2018

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Duke University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Phenotypic and genotypic treatment-related symptom associations will be evaluated in children and adolescents 3-18 years of age with a diagnosis of leukemia.

Exclusion Criteria

•Children without a definite diagnosis of leukemia will be excluded.
•Children must be able to understand and answer the questions on the questionnaires.
•Children with have a cognitive impairment (e.g. Down syndrome) will not be able to complete the questionnaires and will not be eligible for the study.